Calcium Acetate Patent Expiration

Calcium Acetate was first introduced by Fresenius Medical Care North America in its drug Phoslo on Dec 10, 1990. Other drugs containing Calcium Acetate are Phoslyra, Phoslo Gelcaps. 14 different companies have introduced drugs containing Calcium Acetate.

Calcium Acetate Patents

Given below is the list of patents protecting Calcium Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Phoslyra	US8591938	Liquid compositions of calcium acetate	Feb 23, 2030	Fresenius Medcl
Phoslyra	US8592480	Liquid compositions of calcium acetate	Jul 20, 2027	Fresenius Medcl
Phoslyra	US9089528	Liquid compositions of calcium acetate	Jul 20, 2027	Fresenius Medcl
Phoslo Gelcaps	US6875445	Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption	Jul 30, 2021 (Expired)	Fresenius Medcl
Phoslo	US6576665	Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption	Apr 03, 2021 (Expired)	Fresenius Medcl
Phoslo Gelcaps	US6576665	Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption	Apr 03, 2021 (Expired)	Fresenius Medcl

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List